Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD
Abstract There is limited information about the initiation of triple therapy (TT) in patients with chronic obstructive pulmonary disease (COPD) in primary care. This was an observational, population-based study in patients identified from a primary care electronic medical records database in Catalon...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/53f3eceade6c4e54a4020da3b4fd6f5a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:53f3eceade6c4e54a4020da3b4fd6f5a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:53f3eceade6c4e54a4020da3b4fd6f5a2021-12-02T16:36:11ZClinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD10.1038/s41533-021-00227-x2055-1010https://doaj.org/article/53f3eceade6c4e54a4020da3b4fd6f5a2021-03-01T00:00:00Zhttps://doi.org/10.1038/s41533-021-00227-xhttps://doaj.org/toc/2055-1010Abstract There is limited information about the initiation of triple therapy (TT) in patients with chronic obstructive pulmonary disease (COPD) in primary care. This was an observational, population-based study in patients identified from a primary care electronic medical records database in Catalonia from 2011 to 2015 aimed to identify the use of TT in patients with newly diagnosed COPD. A total of 69,668 newly diagnosed patients were identified of whom 11,524 (16.5%) initiated TT, of whom 8626 initiated TT at or immediately after COPD diagnosis. Among them, 72.3% were GOLD A/B, 14.6% were frequent exacerbators, and 7.1% had asthma–COPD overlap (ACO). Variables associated with TT initiation were: male sex, older age, previous exacerbations, ACO, a previous treatment regimen containing an inhaled corticosteroid, previous pneumonia, and history of lung cancer. A significant number of COPD patients in Primary Care initiated TT shortly after or even before an established COPD diagnosis.Mònica MonteagudoMiriam BarrechegurenIryna SolntsevaNafeesa DhalwaniAlison BoothAlexa NuñezDimitra LambrelliMarc MiravitllesNature PortfolioarticleDiseases of the respiratory systemRC705-779ENnpj Primary Care Respiratory Medicine, Vol 31, Iss 1, Pp 1-7 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Diseases of the respiratory system RC705-779 |
spellingShingle |
Diseases of the respiratory system RC705-779 Mònica Monteagudo Miriam Barrecheguren Iryna Solntseva Nafeesa Dhalwani Alison Booth Alexa Nuñez Dimitra Lambrelli Marc Miravitlles Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD |
description |
Abstract There is limited information about the initiation of triple therapy (TT) in patients with chronic obstructive pulmonary disease (COPD) in primary care. This was an observational, population-based study in patients identified from a primary care electronic medical records database in Catalonia from 2011 to 2015 aimed to identify the use of TT in patients with newly diagnosed COPD. A total of 69,668 newly diagnosed patients were identified of whom 11,524 (16.5%) initiated TT, of whom 8626 initiated TT at or immediately after COPD diagnosis. Among them, 72.3% were GOLD A/B, 14.6% were frequent exacerbators, and 7.1% had asthma–COPD overlap (ACO). Variables associated with TT initiation were: male sex, older age, previous exacerbations, ACO, a previous treatment regimen containing an inhaled corticosteroid, previous pneumonia, and history of lung cancer. A significant number of COPD patients in Primary Care initiated TT shortly after or even before an established COPD diagnosis. |
format |
article |
author |
Mònica Monteagudo Miriam Barrecheguren Iryna Solntseva Nafeesa Dhalwani Alison Booth Alexa Nuñez Dimitra Lambrelli Marc Miravitlles |
author_facet |
Mònica Monteagudo Miriam Barrecheguren Iryna Solntseva Nafeesa Dhalwani Alison Booth Alexa Nuñez Dimitra Lambrelli Marc Miravitlles |
author_sort |
Mònica Monteagudo |
title |
Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD |
title_short |
Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD |
title_full |
Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD |
title_fullStr |
Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD |
title_full_unstemmed |
Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD |
title_sort |
clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with copd |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/53f3eceade6c4e54a4020da3b4fd6f5a |
work_keys_str_mv |
AT monicamonteagudo clinicalcharacteristicsandfactorsassociatedwithtripletherapyuseinnewlydiagnosedpatientswithcopd AT miriambarrecheguren clinicalcharacteristicsandfactorsassociatedwithtripletherapyuseinnewlydiagnosedpatientswithcopd AT irynasolntseva clinicalcharacteristicsandfactorsassociatedwithtripletherapyuseinnewlydiagnosedpatientswithcopd AT nafeesadhalwani clinicalcharacteristicsandfactorsassociatedwithtripletherapyuseinnewlydiagnosedpatientswithcopd AT alisonbooth clinicalcharacteristicsandfactorsassociatedwithtripletherapyuseinnewlydiagnosedpatientswithcopd AT alexanunez clinicalcharacteristicsandfactorsassociatedwithtripletherapyuseinnewlydiagnosedpatientswithcopd AT dimitralambrelli clinicalcharacteristicsandfactorsassociatedwithtripletherapyuseinnewlydiagnosedpatientswithcopd AT marcmiravitlles clinicalcharacteristicsandfactorsassociatedwithtripletherapyuseinnewlydiagnosedpatientswithcopd |
_version_ |
1718383633871405056 |